1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Gerresheimer AG
  6. News
  7. Summary
    GXI   DE000A0LD6E6

GERRESHEIMER AG

(GXI)
  Report
Real-time Estimate Tradegate  -  05/17 11:11:25 am EDT
67.10 EUR   +1.36%
05/16GERRESHEIMER AG : Gerresheimer executes on its growth strategy in Emerging Markets boosting capacities in India
EQ
05/11GERRESHEIMER AG : Berenberg reaffirms its Buy rating
MD
05/09Gerresheimer and Portal Enter Strategic Partnership to Treat Chronically Ill Patients with Innovative Needle-Free Drug-Delivery Solution
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Gerresheimer Ag Successfully Issues Promissory Loan Transaction Again Significantly Oversubscribed

11/23/2021 | 09:01am EDT

Gerresheimer AG has reached another milestone in the realization of its financing strategy by successfully issuing a new promissory loan. The total volume amounts to EUR 150 m, with the funds helping the company to further improve its financing costs. The transaction was once again significantly oversubscribed due to favorable conditions. The promissory loan tranches have terms of three and five years and feature fixed and variable rates of interest. The funds from the promissory loans will be used to settle the repayments due in 2022 of certain tranches from previous promissory loan transactions. Repayments for the refinanced promissory loans will be disbursed in September 2022 and November 2022. Up until this point, proceeds from the current promissory loan issue will be utilized to reduce the drawdown on the Gerresheimer AG revolving credit facility. The transaction was supervised by Commerzbank, Landesbank Baden-Wrttemberg, and UniCredit.


© S&P Capital IQ 2021
All news about GERRESHEIMER AG
05/16GERRESHEIMER AG : Gerresheimer executes on its growth strategy in Emerging Markets boostin..
EQ
05/11GERRESHEIMER AG : Berenberg reaffirms its Buy rating
MD
05/09Gerresheimer and Portal Enter Strategic Partnership to Treat Chronically Ill Patients w..
CI
05/09GERRESHEIMER AG : Gerresheimer and Portal enter strategic partnership to treat chronically..
EQ
04/13GERRESHEIMER AG : Credit Suisse reiterates its Buy rating
MD
04/12GERRESHEIMER AG : JP Morgan gives a Neutral rating
MD
04/11GERRESHEIMER AG : Gets a Buy rating from Deutsche Bank
MD
04/08GERRESHEIMER AG : Deutsche Bank keeps its Buy rating
MD
04/07GLOBAL MARKETS LIVE : Airbus, Berkshire Hathaway, Meta, Samsung, Tesla...
04/07TRANSCRIPT : Gerresheimer AG, Q1 2022 Earnings Call, Apr 07, 2022
CI
More news
Analyst Recommendations on GERRESHEIMER AG
More recommendations
Financials
Sales 2022 1 687 M 1 755 M 1 755 M
Net income 2022 117 M 122 M 122 M
Net Debt 2022 1 050 M 1 093 M 1 093 M
P/E ratio 2022 17,7x
Yield 2022 2,01%
Capitalization 2 079 M 2 163 M 2 163 M
EV / Sales 2022 1,85x
EV / Sales 2023 1,72x
Nbr of Employees 10 625
Free-Float 100%
Chart GERRESHEIMER AG
Duration : Period :
Gerresheimer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GERRESHEIMER AG
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 66,20 €
Average target price 92,11 €
Spread / Average Target 39,1%
EPS Revisions
Managers and Directors
Dietmar Siemssen Chief Executive Officer
Bernd Metzner Chief Financial Officer
Axel Herberg Chairman-Supervisory Board
Theodor Stuth Member-Supervisory Board
Udo Johannes Vetter Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
GERRESHEIMER AG-21.84%2 163
ABBOTT LABORATORIES-22.05%192 096
MEDTRONIC PLC0.35%139 265
BECTON, DICKINSON AND COMPANY2.90%72 090
BAXTER INTERNATIONAL INC.-14.15%37 105
HOYA CORPORATION-25.51%36 034